1. Özdemir İH, Özlek B, Özen MB, Gündüz R, Çetin N, Özlek E, et al. Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients. Clin Exp Hypertens. 2021 Oct; 43(7): 683-89. doi: 10.1080/10641963.2021.1937205. [ DOI] [ PubMed] 2. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of Hypertension in Iran 1980-2012: A Systematic Review. J Tehran Heart Cent. 2016 Oct; 11(4): 159-67. [ PubMed] 3. Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020 Nov; 132(8): 749-55. doi: 10.1080/00325481.2020.1786964. [ DOI] [ PubMed] 4. Fang X, Li S, Yu H, Wang P, Zhang Y, Chen Z, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging (Albany NY). 2020 Jul; 12(13): 12493-503. doi: 10.18632/aging.103579. [ DOI] [ PubMed] 5. Rodilla E, Saura A, Jiménez I, Mendizábal A, Pineda-Cantero A, Lorenzo-Hernández E, et al. Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19. J Clin Med. 2020 Sep; 9(10): 3136. doi: 10.3390/jcm9103136. [ DOI] [ PubMed] 6. Hasani Azad M, Khorrami F, Kazemi Jahromi M, Alishan Karami N, Shahi M, Davari Dolatabadi N, et al. Clinical and Epidemiological Characteristics of Hospitalized COVID-19 Patients in Hormozgan, Iran: A Retrospective, Multicenter Study. Arch Iran Med. 2021 May; 24(5): 434-44. doi: 10.34172/aim.2021.62. [ DOI] [ PubMed] 7. Sohrabi MR, Amin R, Maher A, Bahadorimonfared A, Janbazi S, Hannani K, et al. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran. BMC Infect Dis. 2021 May; 21(1): 474. doi: 10.1186/s12879-021-06179-4. [ DOI] [ PubMed] 8. Kabootari M, Habibi Tirtashi R, Hasheminia M, Bozorgmanesh M, Khalili D, Akbari H, et al. Clinical features, risk factors and a prediction model for in-hospital mortality among diabetic patients infected with COVID-19: data from a referral centre in Iran. Public Health. 2022 Jan; 202: 84-92. doi: 10.1016/j.puhe.2021.11.007. [ DOI] [ PubMed] 9. Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020 Jun; 382(25): 2441-48. doi: 10.1056/NEJMoa2008975. [ DOI] [ PubMed] 10. Saylik F, Akbulut T, Kaya S. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension? Angiology. 2021 Nov; 72(10): 947-52. doi: 10.1177/00033197211012145. [ DOI] [ PubMed] 11. Soleimani A, Kazemian S, Karbalai Saleh S, Aminorroaya A, Shajari Z, Hadadi A, et al. Effects of Angiotensin Receptor Blockers (ARBs) on In-Hospital Outcomes of Patients With Hypertension and Confirmed or Clinically Suspected COVID-19. Am J Hypertens. 2020 Dec; 33(12): 1102-11. doi: 10.1093/ajh/hpaa149. [ DOI] [ PubMed] 12. Mirjalili M, Soodejani MT, Raadabadi M, Dehghani A, Salemi F. Does Losartan reduce the severity of COVID-19 in hypertensive patients? BMC Cardiovasc Disord. 2022 Mar; 22(1): 116. doi: 10.1186/s12872-022-02548-2. [ DOI] [ PubMed] 13. He C, Liu C, Yang J, Tan H, Ding X, Gao X, et al. Prognostic significance of day-by-day in-hospital blood pressure variability in COVID-19 patients with hypertension. J Clin Hypertens (Greenwich). 2022 Mar; 24(3): 224-33. doi: 10.1111/jch.14437. [ DOI] [ PubMed] 14. World Health Organization. Algorithm for COVID-19 triage and referral : patient triage and referral for resource-limited settings during community transmission. 2020. WPR/DSE/2020/009. [ Link] 15. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020 Jan. WHO/nCoV/Clinical/2020.3. [ Link] 16. Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied Logistic Regression. 3rd ed. New York: John Wiley & Sons, Inc. 2013; pp: 160-63. 17. Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, Dos Santos TM, Mazza L, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Jan; 325(3): 254-64. doi: 10.1001/jama.2020.25864. [ DOI] [ PubMed] 18. Li Y, Yao L, Li J, Chen L, Song Y, Cai Z, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19. J Med Virol. 2020 Jul; 92(7): 903-908. doi: 10.1002/jmv.25786. [ DOI] [ PubMed] 19. Rastad H, Karim H, Ejtahed HS, Tajbakhsh R, Noorisepehr M, Babaei M, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020 Jul; 12: 57. doi: 10.1186/s13098-020-00565-9. [ DOI] [ PubMed] 20. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Aug; 296(2): E32-E40. doi: 10.1148/radiol.2020200642. [ DOI] [ PubMed] 21. 21. Davarpanah AH, Mahdavi A, Sabri A, Langroudi TF, Kahkouee S, Haseli S, et al. Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service. J Am Coll Radiol. 2020 Jun; 17(6): 734-38. doi: 10.1016/j.jacr.2020.03.015. [ DOI] [ PubMed] |
